€541.40
Your prediction
Thermo Fisher Scientific Inc. Stock
Pros and Cons of Thermo Fisher Scientific Inc. in the next few years
Pros
Cons
Performance of Thermo Fisher Scientific Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Thermo Fisher Scientific Inc. | -0.630% | -1.186% | 6.386% | 7.892% | 12.324% | 15.142% | 124.043% |
Illumina Inc. | 0.810% | -0.710% | 10.272% | -22.194% | -8.607% | -71.159% | -53.230% |
Waters Corp. | -0.260% | -1.481% | 10.310% | 22.400% | 1.325% | -11.047% | 61.443% |
Boston Scientific | -1.390% | 0.000% | -2.069% | 53.182% | 38.025% | 89.586% | 92.022% |
![Hi, I am the sharewise BeanCounterBot. I am digging through tons of financial data to give you a brief summary. I am not perfect but hopefully helpful](/assets/chat-9828e04e1fb016b9d37708c0616b4967f024986270e9f6aa795b8e10e9795a24.png)
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon examining the submitted financials of Thermo Fisher Scientific Inc., symbol TMO, the initial impression is that the company stands robust in its fiscal health. A key point that stands out from the balance sheets of the last three years is the consistent growth in total assets, suggesting an expanding business operation. Moreover, the ability of the company to generate significant net income, as seen from the income statements, reveals strong company profitability and operational efficiency. As for the cash flow statements, they reflect a company that efficiently converts its earnings into cash, which is critical for maintaining liquidity and funding operations.
** - Rising Total Assets: In the past three years, total assets of TMO have shown an upward trajectory, from $69.05 billion in 2020 to nearly $97.29 billion by the end of 2022. Such an increase indicates strategic acquisitions or growth in the company's operations. - Decreasing Debt-to-Equity Ratio: The total liabilities in comparison to the stockholder equity have decreased from 2020's parity level to a more prudent ratio in 2022. This suggests an improved financial stability and lowered financial risk. - Stable Cash Position: TMO's cash reserves are healthy, with a significant jump between 2020 and 2022, from $10.33 billion to $8.52 billion, which is essential for buffering against market volatility or unexpected expenses. - Strong Net Income Performance: The company's ability to generate profit is evident, with net income showing a consistent rise—from $6.38 billion in 2020 to $6.95 billion in 2022. - Solid Return on Equity (ROE): The Return on Equity has been impressive, highlighting the company’s ability to generate income from the investment of its shareholders, with an ROE of 0.1328. - Appreciable Free Cash Flow: Free cash flow figures are impressive, signifying the firm's ability to generate cash after funding the expansion of their asset base, with a free cash flow of $6.91 billion in 2022.
** - Growing Intangibles and Goodwill: The balance sheet shows a large proportion of intangible assets and goodwill, which can be a cause for concern as these values are susceptible to write-downs if acquisitions do not perform as expected. - Net Tangible Assets in the Negative: The negative net tangible assets figure indicates that the company's valuation heavily relies on intangible assets, which could result in volatility if the intrinsic value of these intangibles changes significantly. - Higher Composition of Long-term Debt: An increase in long-term debt from about $19.11 billion in 2020 to $28.91 billion in 2022 may signal aggressive financing that could pose risks if not managed properly. - Declining Revenue Growth: The revenue has seen a slight decline year-over-year, which might be a point of concern for growth trajectory expectations.
Comments